GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$3.97
Tradestie Score
40
Market Cap
$267.77M
Analyst Upside
+177.2%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$15.00
|
$407.71M | - | 37 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$15.31
|
$386.68M | - | 33 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.86
|
$382.04M | - | 48 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.66
|
$371.64M | - | 34 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$22.33
|
$354.45M | - | 31 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$48.38
|
$353.70M | - | 38 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.63
|
$350.98M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.11
|
$341.56M | - | 43 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.12
|
$332.96M | - | 40 | Compare |
|
REPL
Replimune Group, Inc.
|
$14.89
|
$328.62M | - | 29 | Compare |
More GALT Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry